BlackRock’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $719K | Sell |
89,849
-207,299
| -70% | -$1.66M | ﹤0.01% | 4289 |
|
|
2025
Q1 | $2.9M | Buy |
297,148
+9,832
| +3% | +$96K | ﹤0.01% | 3830 |
|
|
2024
Q4 | $3.63M | Sell |
287,316
-24,999
| -8% | -$316K | ﹤0.01% | 3801 |
|
|
2024
Q3 | $5.02M | Buy |
312,315
+7,336
| +2% | +$118K | ﹤0.01% | 3649 |
|
|
2024
Q2 | $7.44M | Sell |
304,979
-4,040
| -1% | -$98.6K | ﹤0.01% | 3484 |
|
|
2024
Q1 | $22.2M | Buy |
309,019
+2,388
| +0.8% | +$172K | ﹤0.01% | 2880 |
|
|
2023
Q4 | $61M | Buy |
306,631
+16,779
| +6% | +$3.34M | ﹤0.01% | 2311 |
|
|
2023
Q3 | $38.5M | Buy |
289,852
+18,046
| +7% | +$2.4M | ﹤0.01% | 2518 |
|
|
2023
Q2 | $40.7M | Buy |
271,806
+343
| +0.1% | +$51.3K | ﹤0.01% | 2567 |
|
|
2023
Q1 | $39.9M | Buy |
271,463
+33,522
| +14% | +$4.92M | ﹤0.01% | 2566 |
|
|
2022
Q4 | $37.7M | Sell |
237,941
-19,891
| -8% | -$3.15M | ﹤0.01% | 2623 |
|
|
2022
Q3 | $49.6M | Buy |
257,832
+759
| +0.3% | +$146K | ﹤0.01% | 2412 |
|
|
2022
Q2 | $37.5M | Buy |
257,073
+31,840
| +14% | +$4.65M | ﹤0.01% | 2646 |
|
|
2022
Q1 | $39.6M | Buy |
225,233
+49
| +0% | +$8.62K | ﹤0.01% | 2672 |
|
|
2021
Q4 | $66.2M | Sell |
225,184
-12,169
| -5% | -$3.58M | ﹤0.01% | 2440 |
|
|
2021
Q3 | $59M | Buy |
237,353
+36,270
| +18% | +$9.01M | ﹤0.01% | 2523 |
|
|
2021
Q2 | $51.1M | Buy |
201,083
+27,173
| +16% | +$6.91M | ﹤0.01% | 2650 |
|
|
2021
Q1 | $30.9M | Buy |
173,910
+912
| +0.5% | +$162K | ﹤0.01% | 2884 |
|
|
2020
Q4 | $27.3M | Buy |
172,998
+24,318
| +16% | +$3.84M | ﹤0.01% | 2782 |
|
|
2020
Q3 | $38.3M | Buy |
148,680
+5,788
| +4% | +$1.49M | ﹤0.01% | 2395 |
|
|
2020
Q2 | $33.2M | Buy |
142,892
+75,458
| +112% | +$17.5M | ﹤0.01% | 2473 |
|
|
2020
Q1 | $11.5M | Buy |
67,434
+60,064
| +815% | +$10.2M | ﹤0.01% | 2883 |
|
|
2019
Q4 | $1.63M | Buy |
+7,370
| New | +$1.63M | ﹤0.01% | 3788 |
|